nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Pamidronate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Pamidronate—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Pamidronate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Pamidronate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Pamidronate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Pamidronate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000531	0.000531	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Pamidronate—Infection—Etoposide—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Pamidronate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000527	0.000527	CcSEcCtD
Pamidronate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000526	0.000526	CcSEcCtD
Pamidronate—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000525	CcSEcCtD
Pamidronate—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Pamidronate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000521	0.000521	CcSEcCtD
Pamidronate—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Pamidronate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Pamidronate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Pamidronate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Pamidronate—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Pamidronate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Pamidronate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Pamidronate—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00051	CcSEcCtD
Pamidronate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Pamidronate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000504	0.000504	CcSEcCtD
Pamidronate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000502	0.000502	CcSEcCtD
Pamidronate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Pamidronate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Pamidronate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Pamidronate—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Pamidronate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Pamidronate—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00049	0.00049	CcSEcCtD
Pamidronate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000487	0.000487	CcSEcCtD
Pamidronate—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000484	CcSEcCtD
Pamidronate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000483	0.000483	CcSEcCtD
Pamidronate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000481	0.000481	CcSEcCtD
Pamidronate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Pamidronate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Pamidronate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Pamidronate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000472	0.000472	CcSEcCtD
Pamidronate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Pamidronate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00047	0.00047	CcSEcCtD
Pamidronate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Pamidronate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Pamidronate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000467	0.000467	CcSEcCtD
Pamidronate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000466	0.000466	CcSEcCtD
Pamidronate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000463	0.000463	CcSEcCtD
Pamidronate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000462	0.000462	CcSEcCtD
Pamidronate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Pamidronate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Pamidronate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Pamidronate—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000455	CcSEcCtD
Pamidronate—Pain—Etoposide—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Pamidronate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Pamidronate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Pamidronate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000454	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000453	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.00045	CcSEcCtD
Pamidronate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00045	CcSEcCtD
Pamidronate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Pamidronate—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Pamidronate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Pamidronate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Pamidronate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Pamidronate—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Pamidronate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Pamidronate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Pamidronate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Pamidronate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Pamidronate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.000429	CcSEcCtD
Pamidronate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Pamidronate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Pamidronate—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Pamidronate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Pamidronate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Pamidronate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Pamidronate—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000419	CcSEcCtD
Pamidronate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000417	0.000417	CcSEcCtD
Pamidronate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000416	0.000416	CcSEcCtD
Pamidronate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Pamidronate—Rash—Vincristine—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Pamidronate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000412	CcSEcCtD
Pamidronate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000412	CcSEcCtD
Pamidronate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Pamidronate—Headache—Vincristine—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000405	CcSEcCtD
Pamidronate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000403	CcSEcCtD
Pamidronate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Pamidronate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000392	CcSEcCtD
Pamidronate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Pamidronate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Pamidronate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Pamidronate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000383	CcSEcCtD
Pamidronate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Pamidronate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Pamidronate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Pamidronate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Pamidronate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Pamidronate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Pamidronate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.00037	CcSEcCtD
Pamidronate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Pamidronate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Pamidronate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Pamidronate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Pamidronate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000365	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000362	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Pamidronate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Pamidronate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Pamidronate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000354	CcSEcCtD
Pamidronate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Pamidronate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000351	0.000351	CcSEcCtD
Pamidronate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000351	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000349	CcSEcCtD
Pamidronate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Pamidronate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000344	0.000344	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Pamidronate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Pamidronate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Pamidronate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Pamidronate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Pamidronate—Rash—Etoposide—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Pamidronate—Headache—Etoposide—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Pamidronate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Pamidronate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000329	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Pamidronate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Pamidronate—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000327	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Pamidronate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000321	CcSEcCtD
Pamidronate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Pamidronate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Pamidronate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Pamidronate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000315	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000313	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000312	CcSEcCtD
Pamidronate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Pamidronate—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00031	CcSEcCtD
Pamidronate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000309	CcSEcCtD
Pamidronate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000304	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Pamidronate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Pamidronate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Pamidronate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Pamidronate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Pamidronate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000295	CcSEcCtD
Pamidronate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000293	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Pamidronate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Pamidronate—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Pamidronate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Pamidronate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Pamidronate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Pamidronate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Pamidronate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Pamidronate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Pamidronate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000269	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000269	CcSEcCtD
Pamidronate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Pamidronate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Pamidronate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Pamidronate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Pamidronate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Pamidronate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Pamidronate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Pamidronate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Pamidronate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Pamidronate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000242	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Pamidronate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000236	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000236	CcSEcCtD
Pamidronate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Pamidronate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000227	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000225	CcSEcCtD
Pamidronate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000219	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Pamidronate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000214	CcSEcCtD
Pamidronate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Pamidronate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000204	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000203	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000198	CcSEcCtD
Pamidronate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000197	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Pamidronate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000188	CcSEcCtD
Pamidronate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000188	CcSEcCtD
Pamidronate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000188	CcSEcCtD
Pamidronate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000182	CcSEcCtD
Pamidronate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000177	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Pamidronate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000174	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000174	CcSEcCtD
Pamidronate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000173	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000164	CcSEcCtD
